The second ADEV paper was chosen to exemplify different aspects to the Neubig series and is also the subject of a recent blogpost. It was published recently from a consortium of no less than 77 authors supported by six non-commercial grants centred on the University of Dundee ('Lysyl-tRNA synthetase as a drug target in malaria and cryptosporidiosis . It turns out this same malarial enzyme had already been curated by the Guide to Malaria Pharmacology (target 3059) for cladosporin (ligand ID 10247).